AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 162 min read$SNPS

Ghazi Sassine sold $6.7M of SNPS

Ghazi Sassine (PRESIDENT AND CEO) sold 14,603 shares of SYNOPSYS INC (SNPS) at $458.96 ($6.70M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ghazi Sassine
Published Jun 16, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosure can slightly influence sentiment, but it does not introduce new fundamentals; the pre-arranged nature lowers interpretability as a near-term negative catalyst.

02

Market read

A single-day CEO sale (~$6.7M) is disclosed; likely modest sentiment impact only.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or regulatory/product news, the signal is typically weak.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-16 for a sale executed 2026-06-15

Background

The article is an SEC Form 4 insider transaction: CEO Ghazi Sassine sold shares of Synopsys on 10b5-1.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Synopsys CEO Ghazi Sassine sold 14,603 shares for about $6.7M under a pre-arranged 10b5-1 plan disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect should be modest and sentiment-driven rather than catalyst-driven.

Evidence & confidence

The filing is a routine Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, providing no new operating or financial information.

Market effects

Sector

No direct sector read-through; this is company-specific insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • issuer
    Synopsys

    Company whose CEO insider sale is disclosed via SEC Form 4.

  • insider
    Ghazi Sassine

    President and CEO who sold 14,603 shares.

  • trading mechanism
    10b5-1 plan

    Pre-arranged plan that reduces the inference of new private information.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

OCT 27
$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

finance.yahoo.com2 min
OCT 26
$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

investing.com2 min
OCT 22
$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

echo.ie2 min
OCT 20
$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

finimize.com2 min